CompletedNot applicableNCT02899936
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Gary Weil, MDWashington University School of Medicine
- Intervention
- 3 drug dose - IDA(drug)
- Enrollment
- 23789 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2016 – 2018
Study locations (4)
- Ministere de la Sante Publique et de la Population, Port-au-Prince, Haiti
- Vector Control Research Centre, Puducherry, India
- Universitas Indonesia, Jakarta, Indonesia
- Papua New Guinea Institute for Medical Research, Madang, Papua New Guinea
Collaborators
Case Western Reserve University · Indian Council of Medical Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02899936 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.